Literature DB >> 25513774

Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coli.

Elamparithi Jayamani1, Eleftherios Mylonakis.   

Abstract

Effectors are virulence factors that are secreted by bacteria during an infection in order to subvert cellular processes or induce the surveillance system of the host. Pathogenic microorganisms encode effectors, toxins and components of secretion systems that inject the effectors to the host. Escherichia coli is part of the innocuous commensal microbial flora of the gastrointestinal tract. However, pathogenic E. coli can cause diarrheal and extraintestinal diseases. Pathogenic E. coli uses secretion systems to inject an array of effector proteins directly into the host cells. Herein, we discuss the effectors secreted by different pathotypes of E. coli and provide an overview of strategies employed by effectors to target the host cellular and subcellular processes as well as their role in triggering host immune response.

Entities:  

Keywords:  AIEC; EHEC; EPEC; IBD; effectors; immunity; pathogenic E. coli; type secretion system; virulence

Mesh:

Substances:

Year:  2014        PMID: 25513774      PMCID: PMC4189879          DOI: 10.4161/viru.29948

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  88 in total

1.  The EspB protein of enterohaemorrhagic Escherichia coli interacts directly with alpha-catenin.

Authors:  Toshio Kodama; Yukihiro Akeda; Gengo Kono; Akira Takahashi; Kinichi Imura; Tetsuya Iida; Takeshi Honda
Journal:  Cell Microbiol       Date:  2002-04       Impact factor: 3.715

2.  Beyond pattern recognition: five immune checkpoints for scaling the microbial threat.

Authors:  J Magarian Blander; Leif E Sander
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

3.  The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b.

Authors:  Stephanie R Shames; Matthew A Croxen; Wanyin Deng; B Brett Finlay
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

Review 4.  Innate control of adaptive immunity: dendritic cells and beyond.

Authors:  Heung Kyu Lee; Akiko Iwasaki
Journal:  Semin Immunol       Date:  2007-02-05       Impact factor: 11.130

5.  Insulin receptor substrate protein 53kDa (IRSp53) is a negative regulator of myogenic differentiation.

Authors:  Ashish Misra; Bhawana George; Rajamuthiah Rajmohan; Neeraj Jain; Ming Hwa Wong; Ravi Kambadur; Thirumaran Thanabalu
Journal:  Int J Biochem Cell Biol       Date:  2012-03-24       Impact factor: 5.085

6.  EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli.

Authors:  Xuanlin Tu; Israel Nisan; Chen Yona; Emanuel Hanski; Ilan Rosenshine
Journal:  Mol Microbiol       Date:  2003-02       Impact factor: 3.501

Review 7.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

Review 8.  Cell death and infection: a double-edged sword for host and pathogen survival.

Authors:  Hiroshi Ashida; Hitomi Mimuro; Michinaga Ogawa; Taira Kobayashi; Takahito Sanada; Minsoo Kim; Chihiro Sasakawa
Journal:  J Cell Biol       Date:  2011-11-28       Impact factor: 10.539

Review 9.  Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes.

Authors:  Fernando Navarro-Garcia; Antonio Serapio-Palacios; Paul Ugalde-Silva; Gabriela Tapia-Pastrana; Lucia Chavez-Dueñas
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

10.  Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus.

Authors:  Rajmohan Rajamuthiah; Beth Burgwyn Fuchs; Elamparithi Jayamani; Younghoon Kim; Jonah Larkins-Ford; Annie Conery; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more
  8 in total

Review 1.  Targeting of host organelles by pathogenic bacteria: a sophisticated subversion strategy.

Authors:  Pedro Escoll; Sonia Mondino; Monica Rolando; Carmen Buchrieser
Journal:  Nat Rev Microbiol       Date:  2015-11-23       Impact factor: 60.633

Review 2.  Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.

Authors:  Laura Marinela Ailioaie; Gerhard Litscher
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

3.  Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.

Authors:  Harshana Sabharwal; Christoph Cichon; Tobias A Ölschläger; Ulrich Sonnenborn; M Alexander Schmidt
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

4.  Pathogens.

Authors:  J Amaranath Govindan; Gary Ruvkun
Journal:  Virulence       Date:  2014       Impact factor: 5.882

Review 5.  Type Three Secretion System in Attaching and Effacing Pathogens.

Authors:  Meztlli O Gaytán; Verónica I Martínez-Santos; Eduardo Soto; Bertha González-Pedrajo
Journal:  Front Cell Infect Microbiol       Date:  2016-10-21       Impact factor: 5.293

6.  T3SS-Independent Uptake of the Short-Trip Toxin-Related Recombinant NleC Effector of Enteropathogenic Escherichia coli Leads to NF-κB p65 Cleavage.

Authors:  Anne-Sophie Stolle; Stefanie Norkowski; Britta Körner; Jürgen Schmitz; Lena Lüken; Maj Frankenberg; Christian Rüter; M Alexander Schmidt
Journal:  Front Cell Infect Microbiol       Date:  2017-04-13       Impact factor: 5.293

7.  Esophageal feeding tube placement and the associated complications in 248 cats.

Authors:  Craig R Breheny; Alisdair Boag; Alice Le Gal; Sven-Erik Hõim; Matteo Cantatore; Davina Anderson; Tim Nuttall; Marjoie L Chandler; Danièlle A Gunn-Moore
Journal:  J Vet Intern Med       Date:  2019-04-18       Impact factor: 3.333

8.  The Role of the Small Export Apparatus Protein, SctS, in the Activity of the Type III Secretion System.

Authors:  Irit Tseytin; Bosko Mitrovic; Nofar David; Katja Langenfeld; Raz Zarivach; Andreas Diepold; Neta Sal-Man
Journal:  Front Microbiol       Date:  2019-11-13       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.